The Effect of Nasal Continuous Positive Airway Pressure (N-CPAP) on Arterial pCO2 During Spinal Anesthesia
NCT ID: NCT01622647
Last Updated: 2013-09-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2012-07-31
2013-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NCPAP Group
Group of patients that do receive NCPAP treatment
Nasal Continuous Positive Airway Pressure (NCPAP)
Subjects will receive NCPAP
No NCPAP
subjects will not receive NCPAP
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nasal Continuous Positive Airway Pressure (NCPAP)
Subjects will receive NCPAP
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age over 21 years and under 70 years
* Planned surgical procedure is total knee arthroplasty (TKA) to be performed at Cape Fear Hospital
* Body Mass Index less than 40
* The patient and their attending anesthesiologist select spinal anesthesia with intravenous sedation, intrathecal morphine, and femoral nerve block as the preferred anesthesia plan
Exclusion Criteria
* History of Stroke with residual neurologic deficit
* Prior diagnosis of Emphysema, Chronic Bronchitis, Chronic Obstructive Pulmonary Disease, or Asthma, or other chronic lung disease
* Recent history of significant nasal obstruction, epistaxis, or facial abnormality that may interfere with proper fit of a nasal CPAP mask
* Pregnancy
* Mental or other disability preventing a patient from personally giving informed consent
* Chronic narcotic or benzodiazepine treatment or dependency
* Allergy to Midazolam, Fentanyl, or Propofol
* Severe upper respiratory infection within the past three weeks
21 Years
69 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
New Hanover Regional Medical Center
OTHER
American Anesthesiology of the Carolinas
UNKNOWN
Pediatrix
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephen B Smith, MD
Role: PRINCIPAL_INVESTIGATOR
American Anesthesiology of the Carolinas
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New Hanover Regional Medical Center
Wilmington, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2012-Z078-1611
Identifier Type: -
Identifier Source: org_study_id